PMID 35383287.
The Performance Baseline Bundle (DEXA + Comprehensive Blood Panel) costs $405, saving you $30
Medical Exclusions : You may not qualify if you have type 1 diabetes, chronic pancreatitis or medication-induced pancreatitis (GLP-1 related), severe gastrointestinal disease, current gallbladder problems (except post-removal), retinal impairment/diabetic retinopathy, recent bariatric surgery, multiple endocrine neoplasia syndrome type 2 (MEN2), or a history of medullary thyroid cancer
Safety and Tolerability of GLP-1-Based Therapies in Adolescents Despite their effectiveness, GLP-1, dual, and triple agonists have side effects that require careful management: Common Adverse Events Gastrointestinal Symptoms: Nausea (4261%)
J Mass Spectrom
Unlike Ozempic, which is approved for Type 2 diabetes, Wegovy is approved specifically for weight loss in adults and adolescents ages 12 and older